nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—HRH1—atherosclerosis	0.405	1	CbGaD
Desipramine—SLC22A5—Niacin—atherosclerosis	0.0825	0.229	CbGbCtD
Desipramine—CYP2B6—Simvastatin—atherosclerosis	0.0323	0.0895	CbGbCtD
Desipramine—CYP2C19—Rosuvastatin—atherosclerosis	0.0221	0.0612	CbGbCtD
Desipramine—CYP2C19—Simvastatin—atherosclerosis	0.0205	0.0569	CbGbCtD
Desipramine—CYP2C19—Lovastatin—atherosclerosis	0.0201	0.0557	CbGbCtD
Desipramine—CYP2D6—Niacin—atherosclerosis	0.0197	0.0547	CbGbCtD
Desipramine—ABCB1—Ezetimibe—atherosclerosis	0.0178	0.0494	CbGbCtD
Desipramine—ABCB1—Simvastatin—atherosclerosis	0.0165	0.0459	CbGbCtD
Desipramine—ABCB1—Lovastatin—atherosclerosis	0.0162	0.0449	CbGbCtD
Desipramine—ABCB1—Pravastatin—atherosclerosis	0.0162	0.0449	CbGbCtD
Desipramine—CYP2D6—Simvastatin—atherosclerosis	0.0156	0.0432	CbGbCtD
Desipramine—CYP2D6—Pravastatin—atherosclerosis	0.0153	0.0423	CbGbCtD
Desipramine—CYP2D6—Lovastatin—atherosclerosis	0.0153	0.0423	CbGbCtD
Desipramine—CYP3A4—Rosuvastatin—atherosclerosis	0.0107	0.0296	CbGbCtD
Desipramine—CYP3A4—Ezetimibe—atherosclerosis	0.0107	0.0296	CbGbCtD
Desipramine—CYP3A4—Simvastatin—atherosclerosis	0.00992	0.0275	CbGbCtD
Desipramine—CYP3A4—Pravastatin—atherosclerosis	0.0097	0.0269	CbGbCtD
Desipramine—CYP3A4—Lovastatin—atherosclerosis	0.0097	0.0269	CbGbCtD
Desipramine—Raised liver function tests—Niacin—atherosclerosis	0.00216	0.019	CcSEcCtD
Desipramine—Raised liver function tests—Pravastatin—atherosclerosis	0.00213	0.0187	CcSEcCtD
Desipramine—HTR2A—arteriole—atherosclerosis	0.00185	0.119	CbGeAlD
Desipramine—Nightmare—Rosuvastatin—atherosclerosis	0.00132	0.0116	CcSEcCtD
Desipramine—Tingling sensation—Niacin—atherosclerosis	0.00124	0.0109	CcSEcCtD
Desipramine—Gynaecomastia—Rosuvastatin—atherosclerosis	0.00122	0.0108	CcSEcCtD
Desipramine—Numbness—Pravastatin—atherosclerosis	0.00118	0.0104	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Lovastatin—atherosclerosis	0.00116	0.0102	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Ezetimibe—atherosclerosis	0.00114	0.01	CcSEcCtD
Desipramine—Sensory loss—Pravastatin—atherosclerosis	0.00113	0.00995	CcSEcCtD
Desipramine—HTR2A—vein—atherosclerosis	0.0011	0.0712	CbGeAlD
Desipramine—Phosphatase alkaline increased—Simvastatin—atherosclerosis	0.00109	0.00953	CcSEcCtD
Desipramine—Nocturia—Pravastatin—atherosclerosis	0.00106	0.00929	CcSEcCtD
Desipramine—Nightmare—Simvastatin—atherosclerosis	0.00105	0.00921	CcSEcCtD
Desipramine—Gynaecomastia—Lovastatin—atherosclerosis	0.00104	0.00912	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Pravastatin—atherosclerosis	0.000981	0.00862	CcSEcCtD
Desipramine—Gynaecomastia—Simvastatin—atherosclerosis	0.000971	0.00853	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Lovastatin—atherosclerosis	0.000968	0.00851	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Ezetimibe—atherosclerosis	0.00095	0.00834	CcSEcCtD
Desipramine—Nightmare—Pravastatin—atherosclerosis	0.000947	0.00832	CcSEcCtD
Desipramine—Vascular purpura—Lovastatin—atherosclerosis	0.000942	0.00827	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Simvastatin—atherosclerosis	0.000906	0.00796	CcSEcCtD
Desipramine—Vascular purpura—Simvastatin—atherosclerosis	0.000881	0.00774	CcSEcCtD
Desipramine—Gynaecomastia—Pravastatin—atherosclerosis	0.000878	0.00771	CcSEcCtD
Desipramine—Purpura—Lovastatin—atherosclerosis	0.000874	0.00768	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.000819	0.00719	CcSEcCtD
Desipramine—Purpura—Simvastatin—atherosclerosis	0.000817	0.00718	CcSEcCtD
Desipramine—SMPD1—connective tissue—atherosclerosis	0.000814	0.0524	CbGeAlD
Desipramine—Vascular purpura—Pravastatin—atherosclerosis	0.000796	0.00699	CcSEcCtD
Desipramine—Depression—Rosuvastatin—atherosclerosis	0.000764	0.00671	CcSEcCtD
Desipramine—Liver function test abnormal—Ezetimibe—atherosclerosis	0.000763	0.0067	CcSEcCtD
Desipramine—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.000751	0.00659	CcSEcCtD
Desipramine—Jaundice—Rosuvastatin—atherosclerosis	0.000747	0.00656	CcSEcCtD
Desipramine—Purpura—Pravastatin—atherosclerosis	0.000739	0.00649	CcSEcCtD
Desipramine—HTR2A—hindlimb—atherosclerosis	0.000734	0.0473	CbGeAlD
Desipramine—Eosinophilia—Lovastatin—atherosclerosis	0.000721	0.00633	CcSEcCtD
Desipramine—Disturbance in sexual arousal—Niacin—atherosclerosis	0.000718	0.0063	CcSEcCtD
Desipramine—SMPD1—cardiovascular system—atherosclerosis	0.000708	0.0456	CbGeAlD
Desipramine—Eosinophilia—Ezetimibe—atherosclerosis	0.000707	0.00621	CcSEcCtD
Desipramine—Urinary retention—Niacin—atherosclerosis	0.000688	0.00604	CcSEcCtD
Desipramine—Hepatitis—Rosuvastatin—atherosclerosis	0.000688	0.00604	CcSEcCtD
Desipramine—Eosinophilia—Simvastatin—atherosclerosis	0.000674	0.00592	CcSEcCtD
Desipramine—Erectile dysfunction—Lovastatin—atherosclerosis	0.00067	0.00589	CcSEcCtD
Desipramine—Liver function test abnormal—Niacin—atherosclerosis	0.000668	0.00587	CcSEcCtD
Desipramine—Erectile dysfunction—Ezetimibe—atherosclerosis	0.000658	0.00578	CcSEcCtD
Desipramine—Liver function test abnormal—Pravastatin—atherosclerosis	0.000658	0.00578	CcSEcCtD
Desipramine—Azatadine—HRH1—atherosclerosis	0.000651	0.123	CrCbGaD
Desipramine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000636	0.00559	CcSEcCtD
Desipramine—HTR2A—appendage—atherosclerosis	0.00063	0.0406	CbGeAlD
Desipramine—Erectile dysfunction—Simvastatin—atherosclerosis	0.000627	0.00551	CcSEcCtD
Desipramine—SMPD1—adipose tissue—atherosclerosis	0.000624	0.0402	CbGeAlD
Desipramine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000624	0.00548	CcSEcCtD
Desipramine—Jaundice—Ezetimibe—atherosclerosis	0.000621	0.00545	CcSEcCtD
Desipramine—Arrhythmia—Rosuvastatin—atherosclerosis	0.000614	0.0054	CcSEcCtD
Desipramine—Eosinophilia—Pravastatin—atherosclerosis	0.000609	0.00535	CcSEcCtD
Desipramine—Depression—Simvastatin—atherosclerosis	0.000605	0.00532	CcSEcCtD
Desipramine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000595	0.00523	CcSEcCtD
Desipramine—Jaundice—Simvastatin—atherosclerosis	0.000592	0.0052	CcSEcCtD
Desipramine—Hepatitis—Lovastatin—atherosclerosis	0.000583	0.00512	CcSEcCtD
Desipramine—Erectile dysfunction—Niacin—atherosclerosis	0.000576	0.00506	CcSEcCtD
Desipramine—Hepatitis—Ezetimibe—atherosclerosis	0.000571	0.00502	CcSEcCtD
Desipramine—Erectile dysfunction—Pravastatin—atherosclerosis	0.000567	0.00498	CcSEcCtD
Desipramine—Methdilazine—HRH1—atherosclerosis	0.000564	0.106	CrCbGaD
Desipramine—Weight increased—Pravastatin—atherosclerosis	0.00056	0.00492	CcSEcCtD
Desipramine—Depression—Pravastatin—atherosclerosis	0.000547	0.00481	CcSEcCtD
Desipramine—Hepatitis—Simvastatin—atherosclerosis	0.000545	0.00479	CcSEcCtD
Desipramine—Stomatitis—Niacin—atherosclerosis	0.000543	0.00477	CcSEcCtD
Desipramine—Jaundice—Niacin—atherosclerosis	0.000543	0.00477	CcSEcCtD
Desipramine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000541	0.00475	CcSEcCtD
Desipramine—Flushing—Lovastatin—atherosclerosis	0.000541	0.00475	CcSEcCtD
Desipramine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000538	0.00473	CcSEcCtD
Desipramine—Myocardial infarction—Pravastatin—atherosclerosis	0.000538	0.00473	CcSEcCtD
Desipramine—Jaundice—Pravastatin—atherosclerosis	0.000535	0.0047	CcSEcCtD
Desipramine—Flushing—Ezetimibe—atherosclerosis	0.00053	0.00466	CcSEcCtD
Desipramine—Alopecia—Lovastatin—atherosclerosis	0.000515	0.00452	CcSEcCtD
Desipramine—Flushing—Simvastatin—atherosclerosis	0.000506	0.00444	CcSEcCtD
Desipramine—Alopecia—Ezetimibe—atherosclerosis	0.000505	0.00444	CcSEcCtD
Desipramine—Hepatitis—Niacin—atherosclerosis	0.0005	0.0044	CcSEcCtD
Desipramine—Hypoaesthesia—Niacin—atherosclerosis	0.000498	0.00437	CcSEcCtD
Desipramine—Dysgeusia—Lovastatin—atherosclerosis	0.000497	0.00436	CcSEcCtD
Desipramine—Hepatitis—Pravastatin—atherosclerosis	0.000493	0.00433	CcSEcCtD
Desipramine—Confusional state—Rosuvastatin—atherosclerosis	0.000493	0.00433	CcSEcCtD
Desipramine—Hypoaesthesia—Pravastatin—atherosclerosis	0.00049	0.00431	CcSEcCtD
Desipramine—Alopecia—Simvastatin—atherosclerosis	0.000482	0.00423	CcSEcCtD
Desipramine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000478	0.0042	CcSEcCtD
Desipramine—Vision blurred—Lovastatin—atherosclerosis	0.000478	0.0042	CcSEcCtD
Desipramine—Tremor—Lovastatin—atherosclerosis	0.000475	0.00417	CcSEcCtD
Desipramine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000471	0.00413	CcSEcCtD
Desipramine—Tinnitus—Niacin—atherosclerosis	0.000467	0.0041	CcSEcCtD
Desipramine—Dysgeusia—Simvastatin—atherosclerosis	0.000465	0.00408	CcSEcCtD
Desipramine—Flushing—Niacin—atherosclerosis	0.000464	0.00408	CcSEcCtD
Desipramine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000462	0.00405	CcSEcCtD
Desipramine—Tinnitus—Pravastatin—atherosclerosis	0.000459	0.00404	CcSEcCtD
Desipramine—Malaise—Lovastatin—atherosclerosis	0.000457	0.00402	CcSEcCtD
Desipramine—Flushing—Pravastatin—atherosclerosis	0.000457	0.00402	CcSEcCtD
Desipramine—HTR2A—artery—atherosclerosis	0.00045	0.029	CbGeAlD
Desipramine—Malaise—Ezetimibe—atherosclerosis	0.000449	0.00394	CcSEcCtD
Desipramine—Vision blurred—Simvastatin—atherosclerosis	0.000447	0.00393	CcSEcCtD
Desipramine—Arrhythmia—Niacin—atherosclerosis	0.000447	0.00393	CcSEcCtD
Desipramine—Tremor—Simvastatin—atherosclerosis	0.000444	0.0039	CcSEcCtD
Desipramine—Alopecia—Niacin—atherosclerosis	0.000442	0.00388	CcSEcCtD
Desipramine—Insomnia—Rosuvastatin—atherosclerosis	0.000442	0.00388	CcSEcCtD
Desipramine—Ill-defined disorder—Simvastatin—atherosclerosis	0.00044	0.00387	CcSEcCtD
Desipramine—Arrhythmia—Pravastatin—atherosclerosis	0.00044	0.00387	CcSEcCtD
Desipramine—Palpitations—Ezetimibe—atherosclerosis	0.00044	0.00386	CcSEcCtD
Desipramine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000439	0.00385	CcSEcCtD
Desipramine—SMPD1—liver—atherosclerosis	0.000438	0.0282	CbGeAlD
Desipramine—Alopecia—Pravastatin—atherosclerosis	0.000435	0.00382	CcSEcCtD
Desipramine—Anxiety—Lovastatin—atherosclerosis	0.00043	0.00378	CcSEcCtD
Desipramine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00043	0.00378	CcSEcCtD
Desipramine—Hypertension—Ezetimibe—atherosclerosis	0.00043	0.00377	CcSEcCtD
Desipramine—Malaise—Simvastatin—atherosclerosis	0.000428	0.00376	CcSEcCtD
Desipramine—Discomfort—Lovastatin—atherosclerosis	0.000427	0.00375	CcSEcCtD
Desipramine—Dry mouth—Lovastatin—atherosclerosis	0.000422	0.00371	CcSEcCtD
Desipramine—Dysgeusia—Pravastatin—atherosclerosis	0.00042	0.00369	CcSEcCtD
Desipramine—Discomfort—Ezetimibe—atherosclerosis	0.000418	0.00368	CcSEcCtD
Desipramine—Constipation—Rosuvastatin—atherosclerosis	0.000418	0.00367	CcSEcCtD
Desipramine—Confusional state—Lovastatin—atherosclerosis	0.000417	0.00367	CcSEcCtD
Desipramine—Dry mouth—Ezetimibe—atherosclerosis	0.000414	0.00364	CcSEcCtD
Desipramine—Alimemazine—HRH1—atherosclerosis	0.000412	0.0777	CrCbGaD
Desipramine—Vision blurred—Niacin—atherosclerosis	0.000411	0.00361	CcSEcCtD
Desipramine—Confusional state—Ezetimibe—atherosclerosis	0.000409	0.0036	CcSEcCtD
Desipramine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000405	0.00356	CcSEcCtD
Desipramine—Vision blurred—Pravastatin—atherosclerosis	0.000404	0.00355	CcSEcCtD
Desipramine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000403	0.00354	CcSEcCtD
Desipramine—Anxiety—Simvastatin—atherosclerosis	0.000403	0.00354	CcSEcCtD
Desipramine—Tremor—Pravastatin—atherosclerosis	0.000402	0.00353	CcSEcCtD
Desipramine—Discomfort—Simvastatin—atherosclerosis	0.000399	0.00351	CcSEcCtD
Desipramine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000398	0.0035	CcSEcCtD
Desipramine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000398	0.00349	CcSEcCtD
Desipramine—Anorexia—Lovastatin—atherosclerosis	0.000395	0.00347	CcSEcCtD
Desipramine—Confusional state—Simvastatin—atherosclerosis	0.00039	0.00343	CcSEcCtD
Desipramine—Urticaria—Rosuvastatin—atherosclerosis	0.000388	0.00341	CcSEcCtD
Desipramine—Oedema—Simvastatin—atherosclerosis	0.000387	0.0034	CcSEcCtD
Desipramine—Malaise—Pravastatin—atherosclerosis	0.000387	0.0034	CcSEcCtD
Desipramine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000386	0.00339	CcSEcCtD
Desipramine—Palpitations—Niacin—atherosclerosis	0.000385	0.00338	CcSEcCtD
Desipramine—HTR2A—endothelium—atherosclerosis	0.00038	0.0245	CbGeAlD
Desipramine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000379	0.00333	CcSEcCtD
Desipramine—Epinastine—HRH1—atherosclerosis	0.000376	0.071	CrCbGaD
Desipramine—Insomnia—Lovastatin—atherosclerosis	0.000374	0.00329	CcSEcCtD
Desipramine—Paraesthesia—Lovastatin—atherosclerosis	0.000372	0.00327	CcSEcCtD
Desipramine—Hypertension—Pravastatin—atherosclerosis	0.00037	0.00325	CcSEcCtD
Desipramine—Anorexia—Simvastatin—atherosclerosis	0.000369	0.00324	CcSEcCtD
Desipramine—Insomnia—Ezetimibe—atherosclerosis	0.000367	0.00323	CcSEcCtD
Desipramine—Paraesthesia—Ezetimibe—atherosclerosis	0.000365	0.0032	CcSEcCtD
Desipramine—Dyspepsia—Lovastatin—atherosclerosis	0.000364	0.0032	CcSEcCtD
Desipramine—Anxiety—Pravastatin—atherosclerosis	0.000364	0.0032	CcSEcCtD
Desipramine—Dry mouth—Niacin—atherosclerosis	0.000363	0.00319	CcSEcCtD
Desipramine—Discomfort—Pravastatin—atherosclerosis	0.000361	0.00317	CcSEcCtD
Desipramine—Decreased appetite—Lovastatin—atherosclerosis	0.00036	0.00316	CcSEcCtD
Desipramine—Dyspepsia—Ezetimibe—atherosclerosis	0.000357	0.00314	CcSEcCtD
Desipramine—Fatigue—Lovastatin—atherosclerosis	0.000357	0.00314	CcSEcCtD
Desipramine—CYP2C18—liver—atherosclerosis	0.000356	0.0229	CbGeAlD
Desipramine—Oedema—Niacin—atherosclerosis	0.000356	0.00312	CcSEcCtD
Desipramine—Mequitazine—HRH1—atherosclerosis	0.000354	0.0669	CrCbGaD
Desipramine—Constipation—Lovastatin—atherosclerosis	0.000354	0.00311	CcSEcCtD
Desipramine—Confusional state—Pravastatin—atherosclerosis	0.000353	0.0031	CcSEcCtD
Desipramine—Decreased appetite—Ezetimibe—atherosclerosis	0.000353	0.0031	CcSEcCtD
Desipramine—ADRB1—connective tissue—atherosclerosis	0.000352	0.0226	CbGeAlD
Desipramine—HTR2A—blood vessel—atherosclerosis	0.00035	0.0226	CbGeAlD
Desipramine—Asthenia—Rosuvastatin—atherosclerosis	0.00035	0.00308	CcSEcCtD
Desipramine—Insomnia—Simvastatin—atherosclerosis	0.00035	0.00308	CcSEcCtD
Desipramine—Oedema—Pravastatin—atherosclerosis	0.00035	0.00307	CcSEcCtD
Desipramine—Fatigue—Ezetimibe—atherosclerosis	0.00035	0.00307	CcSEcCtD
Desipramine—SLC22A3—connective tissue—atherosclerosis	0.000349	0.0225	CbGeAlD
Desipramine—Paraesthesia—Simvastatin—atherosclerosis	0.000348	0.00305	CcSEcCtD
Desipramine—Constipation—Ezetimibe—atherosclerosis	0.000347	0.00305	CcSEcCtD
Desipramine—Tachycardia—Niacin—atherosclerosis	0.000347	0.00305	CcSEcCtD
Desipramine—Pruritus—Rosuvastatin—atherosclerosis	0.000346	0.00304	CcSEcCtD
Desipramine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000343	0.00301	CcSEcCtD
Desipramine—Feeling abnormal—Lovastatin—atherosclerosis	0.000341	0.003	CcSEcCtD
Desipramine—Dyspepsia—Simvastatin—atherosclerosis	0.000341	0.00299	CcSEcCtD
Desipramine—Anorexia—Niacin—atherosclerosis	0.000339	0.00298	CcSEcCtD
Desipramine—Decreased appetite—Simvastatin—atherosclerosis	0.000337	0.00296	CcSEcCtD
Desipramine—CYP2A6—adipose tissue—atherosclerosis	0.000336	0.0216	CbGeAlD
Desipramine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000335	0.00294	CcSEcCtD
Desipramine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000334	0.00294	CcSEcCtD
Desipramine—Fatigue—Simvastatin—atherosclerosis	0.000334	0.00293	CcSEcCtD
Desipramine—Anorexia—Pravastatin—atherosclerosis	0.000334	0.00293	CcSEcCtD
Desipramine—Hypotension—Niacin—atherosclerosis	0.000332	0.00292	CcSEcCtD
Desipramine—Constipation—Simvastatin—atherosclerosis	0.000331	0.00291	CcSEcCtD
Desipramine—Urticaria—Lovastatin—atherosclerosis	0.000329	0.00289	CcSEcCtD
Desipramine—Abdominal pain—Lovastatin—atherosclerosis	0.000327	0.00287	CcSEcCtD
Desipramine—Body temperature increased—Lovastatin—atherosclerosis	0.000327	0.00287	CcSEcCtD
Desipramine—Maprotiline—HRH1—atherosclerosis	0.000324	0.0612	CrCbGaD
Desipramine—CHRM2—cardiovascular system—atherosclerosis	0.000323	0.0208	CbGeAlD
Desipramine—Dizziness—Rosuvastatin—atherosclerosis	0.000323	0.00284	CcSEcCtD
Desipramine—Urticaria—Ezetimibe—atherosclerosis	0.000323	0.00283	CcSEcCtD
Desipramine—Insomnia—Niacin—atherosclerosis	0.000322	0.00282	CcSEcCtD
Desipramine—Body temperature increased—Ezetimibe—atherosclerosis	0.000321	0.00282	CcSEcCtD
Desipramine—Abdominal pain—Ezetimibe—atherosclerosis	0.000321	0.00282	CcSEcCtD
Desipramine—Paraesthesia—Niacin—atherosclerosis	0.000319	0.0028	CcSEcCtD
Desipramine—Feeling abnormal—Simvastatin—atherosclerosis	0.000319	0.0028	CcSEcCtD
Desipramine—Insomnia—Pravastatin—atherosclerosis	0.000317	0.00278	CcSEcCtD
Desipramine—Somnolence—Niacin—atherosclerosis	0.000316	0.00278	CcSEcCtD
Desipramine—Benazepril—MTHFR—atherosclerosis	0.000315	0.0595	CrCbGaD
Desipramine—Paraesthesia—Pravastatin—atherosclerosis	0.000314	0.00276	CcSEcCtD
Desipramine—Dyspepsia—Niacin—atherosclerosis	0.000313	0.00275	CcSEcCtD
Desipramine—Decreased appetite—Niacin—atherosclerosis	0.000309	0.00271	CcSEcCtD
Desipramine—Dyspepsia—Pravastatin—atherosclerosis	0.000308	0.00271	CcSEcCtD
Desipramine—Rash—Rosuvastatin—atherosclerosis	0.000308	0.00271	CcSEcCtD
Desipramine—Dermatitis—Rosuvastatin—atherosclerosis	0.000308	0.0027	CcSEcCtD
Desipramine—Urticaria—Simvastatin—atherosclerosis	0.000308	0.0027	CcSEcCtD
Desipramine—Abdominal pain—Simvastatin—atherosclerosis	0.000306	0.00269	CcSEcCtD
Desipramine—Body temperature increased—Simvastatin—atherosclerosis	0.000306	0.00269	CcSEcCtD
Desipramine—Headache—Rosuvastatin—atherosclerosis	0.000306	0.00269	CcSEcCtD
Desipramine—ADRB1—cardiovascular system—atherosclerosis	0.000306	0.0197	CbGeAlD
Desipramine—Decreased appetite—Pravastatin—atherosclerosis	0.000304	0.00267	CcSEcCtD
Desipramine—Fatigue—Pravastatin—atherosclerosis	0.000302	0.00265	CcSEcCtD
Desipramine—Constipation—Pravastatin—atherosclerosis	0.000299	0.00263	CcSEcCtD
Desipramine—Asthenia—Lovastatin—atherosclerosis	0.000297	0.00261	CcSEcCtD
Desipramine—CHRM1—cardiovascular system—atherosclerosis	0.000294	0.019	CbGeAlD
Desipramine—SLC22A4—adipose tissue—atherosclerosis	0.000294	0.0189	CbGeAlD
Desipramine—Pruritus—Lovastatin—atherosclerosis	0.000293	0.00257	CcSEcCtD
Desipramine—Asthenia—Ezetimibe—atherosclerosis	0.000291	0.00256	CcSEcCtD
Desipramine—Nausea—Rosuvastatin—atherosclerosis	0.00029	0.00255	CcSEcCtD
Desipramine—Feeling abnormal—Pravastatin—atherosclerosis	0.000288	0.00253	CcSEcCtD
Desipramine—Pruritus—Ezetimibe—atherosclerosis	0.000287	0.00252	CcSEcCtD
Desipramine—Diarrhoea—Lovastatin—atherosclerosis	0.000283	0.00249	CcSEcCtD
Desipramine—Urticaria—Niacin—atherosclerosis	0.000282	0.00248	CcSEcCtD
Desipramine—Body temperature increased—Niacin—atherosclerosis	0.000281	0.00247	CcSEcCtD
Desipramine—Abdominal pain—Niacin—atherosclerosis	0.000281	0.00247	CcSEcCtD
Desipramine—SLC22A1—adipose tissue—atherosclerosis	0.00028	0.018	CbGeAlD
Desipramine—Urticaria—Pravastatin—atherosclerosis	0.000278	0.00244	CcSEcCtD
Desipramine—Asthenia—Simvastatin—atherosclerosis	0.000278	0.00244	CcSEcCtD
Desipramine—Diarrhoea—Ezetimibe—atherosclerosis	0.000278	0.00244	CcSEcCtD
Desipramine—Body temperature increased—Pravastatin—atherosclerosis	0.000277	0.00243	CcSEcCtD
Desipramine—Abdominal pain—Pravastatin—atherosclerosis	0.000277	0.00243	CcSEcCtD
Desipramine—Pruritus—Simvastatin—atherosclerosis	0.000274	0.00241	CcSEcCtD
Desipramine—Dizziness—Lovastatin—atherosclerosis	0.000274	0.0024	CcSEcCtD
Desipramine—ADRB1—adipose tissue—atherosclerosis	0.00027	0.0174	CbGeAlD
Desipramine—Dizziness—Ezetimibe—atherosclerosis	0.000268	0.00236	CcSEcCtD
Desipramine—SLC22A3—adipose tissue—atherosclerosis	0.000268	0.0172	CbGeAlD
Desipramine—Diarrhoea—Simvastatin—atherosclerosis	0.000265	0.00233	CcSEcCtD
Desipramine—Vomiting—Lovastatin—atherosclerosis	0.000263	0.00231	CcSEcCtD
Desipramine—HTR1A—cardiovascular system—atherosclerosis	0.000262	0.0169	CbGeAlD
Desipramine—Rash—Lovastatin—atherosclerosis	0.000261	0.00229	CcSEcCtD
Desipramine—Dermatitis—Lovastatin—atherosclerosis	0.000261	0.00229	CcSEcCtD
Desipramine—Headache—Lovastatin—atherosclerosis	0.000259	0.00228	CcSEcCtD
Desipramine—Vomiting—Ezetimibe—atherosclerosis	0.000258	0.00227	CcSEcCtD
Desipramine—Benazepril—ACE—atherosclerosis	0.000257	0.0485	CrCbGaD
Desipramine—Dizziness—Simvastatin—atherosclerosis	0.000256	0.00225	CcSEcCtD
Desipramine—Rash—Ezetimibe—atherosclerosis	0.000256	0.00225	CcSEcCtD
Desipramine—Dermatitis—Ezetimibe—atherosclerosis	0.000256	0.00225	CcSEcCtD
Desipramine—Asthenia—Niacin—atherosclerosis	0.000255	0.00224	CcSEcCtD
Desipramine—Headache—Ezetimibe—atherosclerosis	0.000254	0.00223	CcSEcCtD
Desipramine—Pruritus—Niacin—atherosclerosis	0.000252	0.00221	CcSEcCtD
Desipramine—Asthenia—Pravastatin—atherosclerosis	0.000251	0.00221	CcSEcCtD
Desipramine—Pruritus—Pravastatin—atherosclerosis	0.000248	0.00218	CcSEcCtD
Desipramine—Vomiting—Simvastatin—atherosclerosis	0.000246	0.00216	CcSEcCtD
Desipramine—Nausea—Lovastatin—atherosclerosis	0.000246	0.00216	CcSEcCtD
Desipramine—Rash—Simvastatin—atherosclerosis	0.000244	0.00214	CcSEcCtD
Desipramine—Dermatitis—Simvastatin—atherosclerosis	0.000244	0.00214	CcSEcCtD
Desipramine—Diarrhoea—Niacin—atherosclerosis	0.000243	0.00214	CcSEcCtD
Desipramine—Headache—Simvastatin—atherosclerosis	0.000243	0.00213	CcSEcCtD
Desipramine—Nausea—Ezetimibe—atherosclerosis	0.000241	0.00212	CcSEcCtD
Desipramine—Prochlorperazine—HRH1—atherosclerosis	0.000241	0.0454	CrCbGaD
Desipramine—Diarrhoea—Pravastatin—atherosclerosis	0.00024	0.0021	CcSEcCtD
Desipramine—CYP2A6—liver—atherosclerosis	0.000235	0.0152	CbGeAlD
Desipramine—Dizziness—Niacin—atherosclerosis	0.000235	0.00207	CcSEcCtD
Desipramine—CHRM3—adipose tissue—atherosclerosis	0.000232	0.015	CbGeAlD
Desipramine—Dizziness—Pravastatin—atherosclerosis	0.000231	0.00203	CcSEcCtD
Desipramine—Nausea—Simvastatin—atherosclerosis	0.00023	0.00202	CcSEcCtD
Desipramine—ABCB1—blood vessel—atherosclerosis	0.00023	0.0148	CbGeAlD
Desipramine—Vomiting—Niacin—atherosclerosis	0.000226	0.00199	CcSEcCtD
Desipramine—Rash—Niacin—atherosclerosis	0.000224	0.00197	CcSEcCtD
Desipramine—Dermatitis—Niacin—atherosclerosis	0.000224	0.00197	CcSEcCtD
Desipramine—Headache—Niacin—atherosclerosis	0.000223	0.00196	CcSEcCtD
Desipramine—Vomiting—Pravastatin—atherosclerosis	0.000223	0.00196	CcSEcCtD
Desipramine—Rash—Pravastatin—atherosclerosis	0.000221	0.00194	CcSEcCtD
Desipramine—Dermatitis—Pravastatin—atherosclerosis	0.000221	0.00194	CcSEcCtD
Desipramine—Headache—Pravastatin—atherosclerosis	0.000219	0.00193	CcSEcCtD
Desipramine—Mianserin—HRH1—atherosclerosis	0.000218	0.0411	CrCbGaD
Desipramine—HRH1—connective tissue—atherosclerosis	0.000215	0.0139	CbGeAlD
Desipramine—ORM1—liver—atherosclerosis	0.000214	0.0138	CbGeAlD
Desipramine—Nausea—Niacin—atherosclerosis	0.000211	0.00186	CcSEcCtD
Desipramine—Nausea—Pravastatin—atherosclerosis	0.000208	0.00183	CcSEcCtD
Desipramine—SLC22A1—liver—atherosclerosis	0.000196	0.0127	CbGeAlD
Desipramine—SLC22A5—adipose tissue—atherosclerosis	0.000195	0.0125	CbGeAlD
Desipramine—Nortriptyline—HRH1—atherosclerosis	0.000195	0.0367	CrCbGaD
Desipramine—CYP2B6—cardiovascular system—atherosclerosis	0.000192	0.0123	CbGeAlD
Desipramine—SLC22A3—liver—atherosclerosis	0.000188	0.0121	CbGeAlD
Desipramine—Trimipramine—HRH1—atherosclerosis	0.000183	0.0346	CrCbGaD
Desipramine—CYP2E1—cardiovascular system—atherosclerosis	0.00018	0.0116	CbGeAlD
Desipramine—HTR2A—connective tissue—atherosclerosis	0.00018	0.0116	CbGeAlD
Desipramine—Promethazine—HRH1—atherosclerosis	0.000176	0.0333	CrCbGaD
Desipramine—Doxepin—HRH1—atherosclerosis	0.000175	0.033	CrCbGaD
Desipramine—HRH1—adipose tissue—atherosclerosis	0.000165	0.0106	CbGeAlD
Desipramine—HTR2A—cardiovascular system—atherosclerosis	0.000156	0.0101	CbGeAlD
Desipramine—Promazine—HRH1—atherosclerosis	0.000155	0.0293	CrCbGaD
Desipramine—CYP2C19—liver—atherosclerosis	0.000151	0.00975	CbGeAlD
Desipramine—Chlorpromazine—HRH1—atherosclerosis	0.000137	0.0258	CrCbGaD
Desipramine—SLC22A5—liver—atherosclerosis	0.000137	0.00879	CbGeAlD
Desipramine—Imipramine—HRH1—atherosclerosis	0.000136	0.0257	CrCbGaD
Desipramine—Amitriptyline—HRH1—atherosclerosis	0.000135	0.0255	CrCbGaD
Desipramine—CYP1A2—liver—atherosclerosis	0.000124	0.00797	CbGeAlD
Desipramine—CYP2B6—liver—atherosclerosis	0.000119	0.00764	CbGeAlD
Desipramine—CYP2E1—liver—atherosclerosis	0.000111	0.00717	CbGeAlD
Desipramine—ABCB1—cardiovascular system—atherosclerosis	0.000102	0.0066	CbGeAlD
Desipramine—HTR2A—liver—atherosclerosis	9.67e-05	0.00623	CbGeAlD
Desipramine—ABCB1—adipose tissue—atherosclerosis	9.04e-05	0.00582	CbGeAlD
Desipramine—CYP3A4—liver—atherosclerosis	8.95e-05	0.00577	CbGeAlD
Desipramine—CYP2D6—liver—atherosclerosis	8.81e-05	0.00567	CbGeAlD
Desipramine—Oxcarbazepine—ALB—atherosclerosis	8.01e-05	0.0151	CrCbGaD
Desipramine—ABCB1—liver—atherosclerosis	6.34e-05	0.00408	CbGeAlD
Desipramine—Acepromazine—ALB—atherosclerosis	6.05e-05	0.0114	CrCbGaD
Desipramine—Clomipramine—ALB—atherosclerosis	4.6e-05	0.00868	CrCbGaD
Desipramine—Nortriptyline—ALB—atherosclerosis	4.49e-05	0.00848	CrCbGaD
Desipramine—Chlorpromazine—ALB—atherosclerosis	3.15e-05	0.00595	CrCbGaD
Desipramine—Amitriptyline—ALB—atherosclerosis	3.12e-05	0.00589	CrCbGaD
Desipramine—CHRM3—Signaling Pathways—IGF1—atherosclerosis	3.17e-06	3.18e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PTGS2—atherosclerosis	3.15e-06	3.16e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PPARA—atherosclerosis	3.15e-06	3.16e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IGF1—atherosclerosis	3.14e-06	3.15e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—MTHFR—atherosclerosis	3.13e-06	3.14e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	3.12e-06	3.12e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CD36—atherosclerosis	3.11e-06	3.12e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—ALB—atherosclerosis	3.09e-06	3.1e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	3.09e-06	3.1e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—VEGFA—atherosclerosis	3.08e-06	3.09e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PPARA—atherosclerosis	3.07e-06	3.08e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.06e-06	3.07e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—STAT3—atherosclerosis	3.05e-06	3.06e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—AGT—atherosclerosis	3.05e-06	3.06e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	3.05e-06	3.06e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—SERPINE1—atherosclerosis	3.04e-06	3.05e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—HMOX1—atherosclerosis	3.03e-06	3.04e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	3.03e-06	3.04e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—ALB—atherosclerosis	3.03e-06	3.04e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	3.02e-06	3.03e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	3.01e-06	3.02e-05	CbGpPWpGaD
Desipramine—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	3.01e-06	3.02e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—APOE—atherosclerosis	2.99e-06	2.99e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	2.98e-06	2.99e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	2.98e-06	2.99e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—AGT—atherosclerosis	2.97e-06	2.98e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CXCL8—atherosclerosis	2.96e-06	2.97e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—IL6—atherosclerosis	2.96e-06	2.97e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—NOS3—atherosclerosis	2.96e-06	2.97e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CAV1—atherosclerosis	2.96e-06	2.97e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—VEGFA—atherosclerosis	2.95e-06	2.96e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—APOA1—atherosclerosis	2.95e-06	2.96e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—MTHFR—atherosclerosis	2.95e-06	2.96e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NOS3—atherosclerosis	2.95e-06	2.96e-05	CbGpPWpGaD
Desipramine—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	2.94e-06	2.95e-05	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—AKT1—atherosclerosis	2.93e-06	2.94e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—STAT3—atherosclerosis	2.92e-06	2.93e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MAPK3—atherosclerosis	2.92e-06	2.93e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—APOE—atherosclerosis	2.91e-06	2.92e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—APOB—atherosclerosis	2.91e-06	2.92e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NOS3—atherosclerosis	2.9e-06	2.91e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—NOS3—atherosclerosis	2.9e-06	2.91e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—IL6—atherosclerosis	2.9e-06	2.91e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NOS3—atherosclerosis	2.9e-06	2.9e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PPARA—atherosclerosis	2.89e-06	2.9e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CAV1—atherosclerosis	2.89e-06	2.9e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NOS3—atherosclerosis	2.89e-06	2.9e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—APOA1—atherosclerosis	2.88e-06	2.89e-05	CbGpPWpGaD
Desipramine—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	2.88e-06	2.89e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NOS3—atherosclerosis	2.88e-06	2.89e-05	CbGpPWpGaD
Desipramine—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	2.86e-06	2.87e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NOS3—atherosclerosis	2.85e-06	2.86e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—IL6—atherosclerosis	2.83e-06	2.84e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TGFB1—atherosclerosis	2.83e-06	2.84e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GSTM1—atherosclerosis	2.83e-06	2.84e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—IL6—atherosclerosis	2.82e-06	2.83e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MMP9—atherosclerosis	2.82e-06	2.83e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AGT—atherosclerosis	2.8e-06	2.81e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MAPK3—atherosclerosis	2.79e-06	2.8e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	2.79e-06	2.8e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—LPL—atherosclerosis	2.78e-06	2.78e-05	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—AKT1—atherosclerosis	2.77e-06	2.78e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MMP9—atherosclerosis	2.76e-06	2.76e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—APOE—atherosclerosis	2.75e-06	2.75e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	2.74e-06	2.75e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	2.73e-06	2.74e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.73e-06	2.74e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	2.73e-06	2.74e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CAV1—atherosclerosis	2.72e-06	2.73e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—APOA1—atherosclerosis	2.71e-06	2.72e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	2.71e-06	2.72e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GPX1—atherosclerosis	2.71e-06	2.72e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTGS2—atherosclerosis	2.71e-06	2.72e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MMP9—atherosclerosis	2.7e-06	2.7e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	2.69e-06	2.7e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MMP9—atherosclerosis	2.68e-06	2.69e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	2.68e-06	2.69e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	2.67e-06	2.68e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	2.67e-06	2.67e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	2.65e-06	2.66e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTGS2—atherosclerosis	2.65e-06	2.66e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CD36—atherosclerosis	2.64e-06	2.65e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CG—atherosclerosis	2.63e-06	2.64e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	2.62e-06	2.63e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CXCL8—atherosclerosis	2.62e-06	2.62e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	2.61e-06	2.62e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	2.61e-06	2.62e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PPARG—atherosclerosis	2.6e-06	2.61e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	2.6e-06	2.61e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	2.57e-06	2.58e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	2.57e-06	2.58e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	2.56e-06	2.57e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	2.55e-06	2.56e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—INS—atherosclerosis	2.55e-06	2.56e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PPARG—atherosclerosis	2.54e-06	2.55e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	2.53e-06	2.54e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	2.53e-06	2.54e-05	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	2.53e-06	2.53e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—STAT3—atherosclerosis	2.51e-06	2.51e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.5e-06	2.51e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—INS—atherosclerosis	2.49e-06	2.5e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—IL6—atherosclerosis	2.49e-06	2.5e-05	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	2.49e-06	2.49e-05	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	2.48e-06	2.49e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	2.48e-06	2.49e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	2.48e-06	2.48e-05	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	2.47e-06	2.48e-05	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	2.47e-06	2.47e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PPARA—atherosclerosis	2.45e-06	2.46e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—STAT3—atherosclerosis	2.45e-06	2.46e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—IL6—atherosclerosis	2.45e-06	2.46e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—IL6—atherosclerosis	2.44e-06	2.45e-05	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	2.44e-06	2.45e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—IL6—atherosclerosis	2.43e-06	2.44e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL6—atherosclerosis	2.43e-06	2.43e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	2.42e-06	2.43e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	2.41e-06	2.41e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	2.4e-06	2.41e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—STAT3—atherosclerosis	2.4e-06	2.4e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	2.39e-06	2.4e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PPARG—atherosclerosis	2.39e-06	2.4e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—STAT3—atherosclerosis	2.38e-06	2.39e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AGT—atherosclerosis	2.37e-06	2.38e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MMP9—atherosclerosis	2.37e-06	2.37e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—INS—atherosclerosis	2.35e-06	2.35e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.34e-06	2.35e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	2.34e-06	2.35e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NFKB1—atherosclerosis	2.34e-06	2.35e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—ALB—atherosclerosis	2.34e-06	2.35e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MMP9—atherosclerosis	2.33e-06	2.34e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—APOE—atherosclerosis	2.33e-06	2.33e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MMP9—atherosclerosis	2.32e-06	2.33e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	2.32e-06	2.33e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MMP9—atherosclerosis	2.32e-06	2.32e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MMP9—atherosclerosis	2.31e-06	2.32e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CAV1—atherosclerosis	2.31e-06	2.31e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	2.3e-06	2.31e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MAPK8—atherosclerosis	2.3e-06	2.31e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—APOA1—atherosclerosis	2.3e-06	2.31e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	2.3e-06	2.31e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—AKT1—atherosclerosis	2.3e-06	2.3e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	2.29e-06	2.3e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	2.29e-06	2.3e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	2.29e-06	2.29e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	2.28e-06	2.29e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—ALB—atherosclerosis	2.28e-06	2.29e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	2.28e-06	2.28e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	2.27e-06	2.28e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	2.26e-06	2.27e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	2.26e-06	2.27e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	2.26e-06	2.27e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	2.26e-06	2.26e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	2.25e-06	2.26e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	2.25e-06	2.26e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	2.25e-06	2.25e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	2.25e-06	2.25e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—APOB—atherosclerosis	2.24e-06	2.25e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	2.24e-06	2.25e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—NOS3—atherosclerosis	2.24e-06	2.24e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	2.22e-06	2.23e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	2.22e-06	2.23e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	2.22e-06	2.22e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	2.21e-06	2.22e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—NOS3—atherosclerosis	2.18e-06	2.19e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.18e-06	2.19e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—ALB—atherosclerosis	2.15e-06	2.16e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—LPL—atherosclerosis	2.14e-06	2.15e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL6—atherosclerosis	2.13e-06	2.14e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—atherosclerosis	2.12e-06	2.13e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—STAT3—atherosclerosis	2.1e-06	2.11e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.1e-06	2.11e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	2.09e-06	2.1e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GPX1—atherosclerosis	2.09e-06	2.1e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	2.09e-06	2.09e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	2.08e-06	2.09e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	2.07e-06	2.08e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—STAT3—atherosclerosis	2.07e-06	2.08e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—STAT3—atherosclerosis	2.07e-06	2.07e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—STAT3—atherosclerosis	2.06e-06	2.07e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—NOS3—atherosclerosis	2.06e-06	2.06e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	2.05e-06	2.06e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—STAT3—atherosclerosis	2.05e-06	2.06e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTGS2—atherosclerosis	2.05e-06	2.05e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL6—atherosclerosis	2.04e-06	2.05e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CD36—atherosclerosis	2.04e-06	2.04e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	2.03e-06	2.04e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PPARG—atherosclerosis	2.03e-06	2.03e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MAPK3—atherosclerosis	2.01e-06	2.02e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTGS2—atherosclerosis	2e-06	2e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—INS—atherosclerosis	1.99e-06	1.99e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	1.98e-06	1.98e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	1.97e-06	1.98e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKT1—atherosclerosis	1.97e-06	1.97e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	1.97e-06	1.97e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	1.96e-06	1.97e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TGFB1—atherosclerosis	1.95e-06	1.96e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	1.94e-06	1.95e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.93e-06	1.93e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	1.92e-06	1.92e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	1.91e-06	1.92e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	1.91e-06	1.91e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	1.9e-06	1.91e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PPARA—atherosclerosis	1.89e-06	1.9e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKT1—atherosclerosis	1.88e-06	1.89e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	1.88e-06	1.89e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.88e-06	1.89e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—AKT1—atherosclerosis	1.84e-06	1.84e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AGT—atherosclerosis	1.83e-06	1.84e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ALB—atherosclerosis	1.82e-06	1.83e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—APOE—atherosclerosis	1.8e-06	1.8e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CAV1—atherosclerosis	1.78e-06	1.78e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—APOA1—atherosclerosis	1.78e-06	1.78e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL6—atherosclerosis	1.75e-06	1.76e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—NOS3—atherosclerosis	1.74e-06	1.75e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—AKT1—atherosclerosis	1.71e-06	1.72e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL6—atherosclerosis	1.71e-06	1.72e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—AKT1—atherosclerosis	1.69e-06	1.69e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL6—atherosclerosis	1.67e-06	1.68e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL6—atherosclerosis	1.67e-06	1.67e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.62e-06	1.63e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKT1—atherosclerosis	1.61e-06	1.62e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.59e-06	1.6e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—AKT1—atherosclerosis	1.58e-06	1.59e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKT1—atherosclerosis	1.58e-06	1.58e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PPARG—atherosclerosis	1.56e-06	1.57e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKT1—atherosclerosis	1.54e-06	1.55e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKT1—atherosclerosis	1.54e-06	1.54e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—INS—atherosclerosis	1.53e-06	1.54e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL6—atherosclerosis	1.47e-06	1.47e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL6—atherosclerosis	1.45e-06	1.45e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL6—atherosclerosis	1.44e-06	1.45e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL6—atherosclerosis	1.44e-06	1.44e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL6—atherosclerosis	1.43e-06	1.44e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL6—atherosclerosis	1.42e-06	1.42e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ALB—atherosclerosis	1.41e-06	1.41e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—AKT1—atherosclerosis	1.36e-06	1.36e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKT1—atherosclerosis	1.36e-06	1.36e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—NOS3—atherosclerosis	1.35e-06	1.35e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKT1—atherosclerosis	1.33e-06	1.34e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—AKT1—atherosclerosis	1.33e-06	1.34e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKT1—atherosclerosis	1.33e-06	1.34e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKT1—atherosclerosis	1.33e-06	1.33e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKT1—atherosclerosis	1.32e-06	1.33e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	1.31e-06	1.31e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.23e-06	1.23e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—AKT1—atherosclerosis	1.03e-06	1.03e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—AKT1—atherosclerosis	1e-06	1.01e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AKT1—atherosclerosis	9.46e-07	9.49e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AKT1—atherosclerosis	8.01e-07	8.04e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKT1—atherosclerosis	6.18e-07	6.2e-06	CbGpPWpGaD
